Impact of Sacubitril/Valsartan (ARNI) Compared with ACEI/ARB in Patients with Acute Myocardial Infarction on Post-Infarction Left Ventricular Systolic Dysfunction: A Retrospective Analysis.

Biomedicines · 2025 · PMC12467660 · PMID 41007826

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

We believe that, despite its limitations, our study provides important conclusions about the use of ARNI in patients with AMI in real-life experience and shows a significant trend in which patients may benefit most from ARNI use.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.